Mucosolvan® is a pharmacy-only drug with the active ingredient Ambroxol hydrochloride, which is used to loosen mucus in acute and chronic lung diseases and diseases of the lower respiratory tract when there is a disruption of mucus formation and mucus transport.
If hypersensitivity (allergy) is known or occurs against one of the ingredients of the medication, the medication must not be used any longer, as this can lead to dangerous damage to health.
It is also not advisable to take Mucosolvan® if there is impaired self-cleaning of the lower airways and large amounts of secretion. Otherwise, secretion could build up in this case.
$config[ads_text1] not found
If kidney function is impaired or if there is a severe liver disease, Mucosolvan® should only be used with extreme caution (i.e. at longer intervals between use or at a reduced dose).
Unless the doctor prescribes a different dose, Mucosolvan is taken as a film-coated tablet in children from 12 years of age and adults as follows:
For the first 2-3 days, ½ tablet is taken 3 times a day (thus 30 mg ambroxol hydrochloride 3 times a day).
Then ½ tablet is taken twice a day (thus 2 times 30 mg ambroxol hydrochloride).
It is possible to increase the effectiveness in adults by taking a whole tablet twice a day (i.e. 60 mg ambroxol hydrochloride twice a day). This can be particularly helpful in the case of pronounced increased secretion production in the lower airways or viscous airway secretions.
The duration of use must be determined individually by the doctor.
The drug should be swallowed whole with a glass of water, juice or tea after meals.$config[ads_text2] not found
As with all drugs, this can also lead to undesirable effects when taken.
These include the following:
Also becomes the anti-cough medicine at the same time as Mucosolvan® Codeine If taken, the resulting reduced cough reflex can lead to a dangerous accumulation of secretions.
The antibiotics amoxicillin, cefuroxime, doxycycline and erythromycin are increasingly absorbed into the bronchial secretion when they are taken in parallel with Mucosolvan®.
According to studies on animals, the drug Mucosolvan® crosses the placental barrier into the blood of the unborn child and also accumulates in breast milk.
The drug Mucosolvan® should not be taken, especially during the first trimester of pregnancy and when breastfeeding, and during the rest of the pregnancy a careful risk-benefit assessment is necessary before the drug is taken so that the child is not harmed.
$config[ads_text3] not found